| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |